Comprehensive Medtech Market Intelligence Platform
One stop shop for global market sizing and analysis, procedure volume data, startup company and deal tracking, curated insights, and more from our trusted medtech analyst team.
See why our global events and trusted market intelligence products and services have been a cornerstone of the industry for nearly two decades.
Join 1,500 Investors, Innovators,
Strategics and More
on the
Pacific
Present,
Speak, or Sponsor
LSI’s Inaugural Event in Asia Pacific, the
Fastest-Growing
Region
in Medtech
Present,
Speak, or Sponsor
Partner with International Executives in
London's
Most Iconic Venue
Present,
Speak, or Sponsor
Join 1,500 Investors, Innovators,
Strategics
and More on the Pacific
Present,
Speak, or Sponsor
LSI’s Inaugural Event in Asia Pacific, the
Fastest-Growing
Region
in Medtech
Present,
Speak, or Sponsor
Partner with International Executives in
London's
Most Iconic Venue
Present,
Speak, or Sponsor
Medtronic's mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.
Murielle Thinard McLane sat down at LSI Europe ‘23 to discuss Intuitive Ventures' strategy and goals.
TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.
Opal Ventures is backing startups that empower people to live healthier, happier, and more productive lives.
We Venture Capital is investing globally in diagnostics start-ups, as well as digital solutions and biotechnology in the diagnostics arena.
Eric Schantz sat down at LSI Europe ‘23 to discuss his role with Medtronic and why Medtronic decides to attend industry events like LSI Europe '23.
Comprehensive Medtech Market Intelligence Platform
One stop shop for global market sizing and analysis, procedure volume data, startup company and deal tracking, curated insights, and more from our trusted medtech analyst team.
Global Medtech Market Analysis & Projections (MAP)
Total market data by segment (2021 - 2031), share by supplier data, and CAGRs (2022 - 2027) on 22 major segments and 200+ technology sub-segments with consistent methodology and forecast periods.
Global Diagnostics and Therapeutic Procedure Volumes Database
Coverage of 200+ procedures across 12 major categories (Orthopedics, General Surgery, Neurosurgery, etc.) in 37 countries spanning the USA, Europe, Asia, and Latin America.
Our in-house team has decades of experience performing critical research and analysis for medtech companies, consulting and private equity firms, and more. Get in touch to learn more about our capabilities.
Schedule an Exploratory CallAssessment of under-treated and under-researched gynecologic procedures for a publicly-traded robotics company
Diligence on a potential deal in the Personal Protective Equipment (PPE) space for a US Private Equity firm
Analysis of the Urinary Catheters market and landscape for an innovative Original Equipment Manufacturer
Our in-house team of industry insiders, market analysts,
media professionals, and events strategists are focused on
one thing — helping you build a breakthrough business.
Scott Pantel
Chief Executive Officer
Henry Peck
Chief Business Officer
Kelly Williams
VP of Business Development
Rebekah Murrietta
VP of Media
Nick Talamantes
Senior Director of Market Intelligence
Scott Pantel
Chief Executive Officer
Henry Peck
Chief Business Officer
Kelly Williams
VP of Business Development
Rebekah Murrietta
VP of Media
Nicholas Talamantes
Senior Director of Market Intelligence
Simplify microsurgery. Say goodbye to manual hand sewing and welcome a new age of simple and efficient microvascular connection.
OstomyCure AS is a Medical Technology company with our HQ in Oslo, Norway. The company has developed a revolutionary technology called Transcutaneous Implant Evacuation Solution, the TIES Solution.
Our Next Event → LSI Europe '24 in Sintra, Portugal, Sept. 16-20th
Our Next Event → LSI USA '24 in Dana Point, California on March 18-22.
The recent EU AI Act has significant penalties and implications for existing and prospecting tech companies and investors. This panel covers these new policies from the perspective of Medtech innovators.
ATRO Medical’s artificial meniscus Artimis® replaces your meniscus. This means you will return to your daily activities, with heavy sports excluded, while reducing chronic pains: a flexible yet strong solution to your knee problems. We are in the clinical phase and investigate the effectiveness of our prostheses.
In this talk, Dr. Catherine Mohr shares her journey with Intuitive Surgical, some wicked problems burdening the world of healthcare, and how Intuitive looks to change the world through access of education.
This panel discusses the importance of building cross-border relationships—nationally or internationally—for investors and innovators alike.
The following panel dives into the evolving field of digital health from an investors and innovators perspective with a focus on how this new changes impacts business models. Topics like remote data collection, telehealth, and digital technology are covered.
The panelists discuss the intricacies of Medtech financing in Europe. Some topics covered include financing rounds, commercialization in US markets, and applying for FDA approval and clearance.
Explore where the industry is heading with data-driven insights and updates from our trusted team
.png)
We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
